Zelek WM - Search Results

1

Characterizing a pH-switch anti-C5 antibody as a tool for human and mouse complement C5 purification and cross-species inhibition of classical and reactive lysis.

Zelek WM, Stott M, Walters D, Harris CL, Morgan BP. Zelek WM, et al. Immunology. 2018 Nov;155(3):396-403. doi: 10.1111/imm.12982. Epub 2018 Jul 30. Immunology. 2018. PMID: 29981529 Free PMC article.

2

Absence of CD59 in Guinea Pigs: Analysis of the Cavia porcellus Genome Suggests the Evolution of a CD59 Pseudogene.

Boshra H, Zelek WM, Hughes TR, Rodriguez de Cordoba S, Morgan BP. Boshra H, et al. Among authors: zelek wm. J Immunol. 2018 Jan 1;200(1):327-335. doi: 10.4049/jimmunol.1701238. Epub 2017 Nov 22. J Immunol. 2018. PMID: 29167230 Free PMC article.

3

Complement system biomarkers in first episode psychosis.

Kopczynska M, Zelek W, Touchard S, Gaughran F, Di Forti M, Mondelli V, Murray R, O'Donovan MC, Morgan BP. Kopczynska M, et al. Schizophr Res. 2019 Feb;204:16-22. doi: 10.1016/j.schres.2017.12.012. Epub 2017 Dec 24. Schizophr Res. 2019. PMID: 29279246 Free PMC article.

4

Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59.

Zelek WM, Watkins LM, Howell OW, Evans R, Loveless S, Robertson NP, Beenes M, Willems L, Brandwijk R, Morgan BP. Zelek WM, et al. Mult Scler. 2019 Apr;25(4):523-531. doi: 10.1177/1352458518758927. Epub 2018 Feb 9. Mult Scler. 2019. PMID: 29421990

5

Complement system biomarkers in epilepsy.

Kopczynska M, Zelek WM, Vespa S, Touchard S, Wardle M, Loveless S, Thomas RH, Hamandi K, Morgan BP. Kopczynska M, et al. Among authors: zelek wm. Seizure. 2018 Aug;60:1-7. doi: 10.1016/j.seizure.2018.05.016. Epub 2018 May 24. Seizure. 2018. PMID: 29857269 Free article.

6

Extracting the barbs from complement assays: Identification and optimisation of a safe substitute for traditional buffers.

Zelek WM, Harris CL, Morgan BP. Zelek WM, et al. Immunobiology. 2018 Dec;223(12):744-749. doi: 10.1016/j.imbio.2018.07.016. Epub 2018 Jul 20. Immunobiology. 2018. PMID: 30033110

7

Development and characterization of novel anti-C5 monoclonal antibodies capable of inhibiting complement in multiple species.

Zelek WM, Taylor PR, Morgan BP. Zelek WM, et al. Immunology. 2019 Aug;157(4):283-295. doi: 10.1111/imm.13083. Epub 2019 Jun 17. Immunology. 2019. PMID: 31120547 Free PMC article.

8

Compendium of current complement therapeutics.

Zelek WM, Xie L, Morgan BP, Harris CL. Zelek WM, et al. Mol Immunol. 2019 Oct;114:341-352. doi: 10.1016/j.molimm.2019.07.030. Epub 2019 Aug 22. Mol Immunol. 2019. PMID: 31446305 Free article. Review.

9

Cerebrospinal fluid complement system biomarkers in demyelinating disease.

Zelek WM, Fathalla D, Morgan A, Touchard S, Loveless S, Tallantyre E, Robertson NP, Morgan BP. Zelek WM, et al. Mult Scler. 2020 Dec;26(14):1929-1937. doi: 10.1177/1352458519887905. Epub 2019 Nov 8. Mult Scler. 2020. PMID: 31701790

10

Characterizing the original anti-C5 function-blocking antibody, BB5.1, for species specificity, mode of action and interactions with C5.

Zelek WM, Menzies GE, Brancale A, Stockinger B, Morgan BP. Zelek WM, et al. Immunology. 2020 Oct;161(2):103-113. doi: 10.1111/imm.13228. Epub 2020 Jul 13. Immunology. 2020. PMID: 32557571 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters